Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fractyl Health (GUTS) Gross Margin (2023 - 2024)

Fractyl Health (GUTS) has disclosed Gross Margin for 2 consecutive years, with 100.0% as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Gross Margin rose 2857.0% year-over-year to 100.0%, compared with a TTM value of 46.24% through Dec 2024, up 1040.0%, and an annual FY2024 reading of 46.24%, up 1040.0% over the prior year.
  • Gross Margin was 100.0% for Q4 2024 at Fractyl Health, up from 50.0% in the prior quarter.
  • Across five years, Gross Margin topped out at 100.0% in Q4 2024 and bottomed at 30.56% in Q3 2023.